• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB ENVISTA TORIC INTRAOCULAR LENS; LENS, INTRAOCULAR, TORIC OPTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB ENVISTA TORIC INTRAOCULAR LENS; LENS, INTRAOCULAR, TORIC OPTICS Back to Search Results
Model Number MX60T
Device Problem Insufficient Information (3190)
Patient Problem Halo (2227)
Event Date 10/08/2020
Event Type  Injury  
Manufacturer Narrative
The lens was returned for evaluation in a plastic specimen cup in a fluid.The part number and serial number could not be verified; however, the lens does have the appearance of the reported lens.Particulates and scratches appeared to be visible on the lens.There was an area on the optic that was cloudy white and had an uneven surface with a frost like pattern.Visual inspection found the lens was cut or torn in half and one haptic was attached to each piece of the optic.One haptic was torn at the loop next to the optic.Due to the device condition, functional and diopter testing could not be performed.A review of the device history record has been performed and there were no anomalies or discrepancies identified that may have contributed to the reported event.A review of non-conformances did not identify any inconsistencies that would contribute to the reported event.The lot history, trend analysis, risk analysis and directions for use review are considered acceptable, with the product performing within anticipated rates.The investigation is ongoing.
 
Event Description
It was reported, one day post operation of a non-complicated phacoemulsification surgery to implant an intraocular lens in the left eye the patient experienced decreased vision due to glare.On slit lamp examination a 1.5mm central clear area was seen surrounded by sub surface refractive particles.The orientation of the lens did not change.Approximately one month after iol implant, the lens was removed and replaced with a lens of a same model and diopter.The patient's current prognosis is good.In the surgeon¿s opinion the most likely cause of the event was a defective iol.
 
Manufacturer Narrative
The iol was returned to b+l for investigation.Upon further analysis through optical inspection, laser confocal microscopy, and slit lamp microscopy, the explanted lens did not exhibit machine marks or unacceptable lathe lines and no other evidence of defects or surface contamination was observed.Based on the results of this evaluation, the root cause of this event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENVISTA TORIC INTRAOCULAR LENS
Type of Device
LENS, INTRAOCULAR, TORIC OPTICS
Manufacturer (Section D)
BAUSCH + LOMB
1400 north goodman street
rochester NY 14609
MDR Report Key11010514
MDR Text Key221513723
Report Number0001313525-2020-00196
Device Sequence Number1
Product Code MJP
Combination Product (y/n)Y
PMA/PMN Number
P910056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 10/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/15/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2022
Device Model NumberMX60T
Device Catalogue NumberMXUET200+205
Device Lot Number222
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/01/2020
Was the Report Sent to FDA? No
Date Manufacturer Received06/28/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AMVISC, BLIS INJECTION SYSTEM; AMVISC, BLIS INJECTION SYSTEM
Patient Outcome(s) Required Intervention;
Patient Age61 YR
-
-